• 1
    Wild SH, Byrne CD, Smith FB, et al. Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study. Diabetes Care. 2006;29:637642.
  • 2
    Feringa HH, Karagiannis SE, Schouten O, et al. Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vas Endovasc Surg. 2007;34:206213.
  • 3
    Sutton-Tyrrell K, Venkitachalam L, Kanaya AM, et al. The Health, Aging, and Body Composition Study. Stroke. 2008;39:863869.
  • 4
    Leng GC, Fowkes FGR, Lee AJ, et al. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996;313:14401444.
  • 5
    Makowsky MJ, McAlister FA, Galbraith PD, et al. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance care gaps, and impact of therapy. Am Heart J. 2008;155:348355.
  • 6
    Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;21:20532206.
  • 7
    Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683689.
  • 8
    Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:27092716.
  • 9
    Isomaa B, Henricsson M, Almgren P, et al. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia. 2001;44:11481154.
  • 10
    Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:12101214.
  • 11
    Conen D, Rexrode KM, Creager MA, et al. Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study. Circulation. 2009;120(12):10411047.
  • 12
    Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism. 1996;45(6):699706.
  • 13
    Després JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med. 2006;38(1):5263.
  • 14
    Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance. The emerging role of the adipocyte as an endocrine organ. N Engl J Med. 2001;345:13451346.
  • 15
    Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:24862497.
  • 16
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539553.
  • 17
    Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469480.
  • 18
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356359.
  • 19
    Qadan LR, Ahmed AA, Safar HA, et al. Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease. Angiology. 2008;59:198202.
  • 20
    Gorter PM, Olijhoek JK, van der Graaf Y, et al. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis. 2004;173:363369.
  • 21
    Brevetti G, Schiano V, Sirico G, et al. Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular morbidity. J Vasc Surg. 2006;44:101107.
  • 22
    Maksimovic M, Vlajinac H, Radak D, et al. Relationship between peripheral arterial disease and metabolic syndrome. Angiology. 2009;60(5):546553.
  • 23
    Olijhoek JK, van der Graaf Y, Banga JD, et al. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004;25:342348.
  • 24
    Wild SH, Byrne CD, Tzoulaki I, et al. Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study. Atherosclerosis. 2009;203(2):604609.
  • 25
    Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442443.
  • 26
    Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev. 2008;29(7):777822.